Anne‐Marie Russell

Author

Anne‐Marie Russell

Also Known As

A M Russell, A RUSSELL, A Russell, A. M. Russell, A. RUSSELL, A. Russell, A.-M. Russell, A.M. Russell, AL Russell, AM Russell

240

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

Imperial College London Royal Brompton Hospital University of Exeter Imperial College Healthcare NHS Trust National Institute for Health Research

About

Anne‐Marie Russell is an author at Imperial College London specializing in medicine, animal science, and pulmonary disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	2.6K
2	Public Health	8	8	343
3	Education	5	5	363
4	Engineering	3	3	76
5	Health Sciences	3	3	133

Anne‐Marie Russell

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
BRCA1 dysfunction in sporadic basal-like breast cancer Nicholas C. Turner, J. S. Reis-Filho, Anne‐Marie Russell, Oncogene Breast OncologyEndocrine-related CancerMedicinePathologyBreast Cancer	2006	563
The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis Philip L. Molyneaux, Michael J. Cox, Saffron A.G. Willis‐Owen, American Journal of Respiratory and Critical Care Medicine	2014	540
FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer Laleh Amiri‐Kordestani, Gideon M. Blumenthal, Qiang Xu, Clinical Cancer Research Metastatic Breast CancerIndependent Review CommitteeBreast OncologyMedicineCancer Management	2014	336
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study Gísli Jenkins, Juliet K. Simpson, Gauri Saini, The Lancet Respiratory Medicine FibrosisAdvanced Lung DiseasePathologyBiomarkersPulmonary Fibrosis	2015	316
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study Toby M. Maher, Eunice Oballa, Juliet K. Simpson, The Lancet Respiratory Medicine InflammationFibrosisIdiopathic Pulmonary FibrosisPulmonary Alveolar ProteinosisBiomarkers	2017	262
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis Carmel Stock, Hiroe Sato, Carmen Fonseca, Thorax	2013	231
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study Thomas M Drake, Annemarie B Docherty, Ewen M. Harrison, American Journal of Respiratory and Critical Care Medicine	2020	228
Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial Dina Visca, Letizia Mori, Vicky Tsipouri, The Lancet Respiratory Medicine Quality Of LifeAdvanced Lung DiseaseFibrotic Lung DiseasePulmonary FibrosisOxygen Therapy	2018	215
U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma Michael D. Axelson, Ke Liu, Xiaoping Jiang, Clinical Cancer Research Regulatory ConsiderationsU.s. FoodMedicineLocally AdvancedCancer Management	2013	182
Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary Fibrosis Anne‐Marie Russell, Huzaifa Adamali, Philip L. Molyneaux, American Journal of Respiratory and Critical Care Medicine	2016	181

Page 1